Feasibility of hybrid-technology upper limb rehabilitation for people with neurological impairments in hospital.
- Conditions
- pper limb impairment from neurological disorderUpper limb impairment from neurological disorderStroke - HaemorrhagicStroke - IschaemicNeurological - Multiple sclerosisNeurological - Parkinson's diseaseNeurological - Other neurological disorders
- Registration Number
- ACTRN12622001564741
- Lead Sponsor
- The University of Queensland
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Rehabilitation inpatients with neurological upper limb impairment caused by stroke (first or recurrent), traumatic or other acquired brain injury, spinal cord injury or other stable neurological condition with sufficient English to provide informed consent and cognitive function to follow instructions during group therapy sessions and the study.
Admitted rehabilitation inpatients with the following will be excluded - motor neuron disease or other deteriorating neurological conditions, patients in post-traumatic amnesia, patients with upper limb disorders from congenital conditions and people with upper limb amputations.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Patient self-reported outcome measure of arm function using Arm Activity Measure (Arm-A).[ Baseline and inpatient discharge.];Upper limb impairment measure using Fugl-Meyer Assessment-Upper Extremity.[ Baseline and inpatient discharge.];Upper limb activity measure using Action Research Arm Test.[ Baseline and inpatient discharge.]
- Secondary Outcome Measures
Name Time Method Participation outcome measure using Community Integration Questionnaire-Revised. (Primary outcome).[ Baseline and inpatient discharge.];Feasibility outcome addressing intervention acceptability using survey designed specifically for this study. [ At inpatient discharge.];Feasibility outcome addressing therapy engagement using Pittsburgh Participation Rating Scale. [ At each upper limb therapy group session.];Feasibility outcome addressing implementation via attendance rates using study data collection form for therapy attendance. [ At each upper limb therapy group session.];Feasibility outcome addressing implementation via therapy intensity (time, repetitions) using <br>study data collection form for therapy dosage. [ At each upper limb therapy group session.];Feasibility outcome addressing intervention efficacy through goal attainment and quality of life (EQ-5D-5L). [ At inpatient discharge]